TFP5 Attenuates Cyclin-Dependent Kinase 5-Mediated Islet β-Cell Damage in Diabetes

By
Bob
-
0
245
Scientists investigated the role of a cyclin-dependent kinase 5 (CDK5) inhibitor, TFP5, in islet β-cell damage under diabetic conditions by regulating the expression of CDK5 in vitro and in vivo.
[Chemical Biology & Drug Design]
Full Article